- category:Business
Business
Nidek and Hoya Vision Care launch global partnership
New agreement focuses on offering patients a wider array of ophthalmic services.
Business
Amazon launches online subscription service for generic drugs
The new service is exclusive to Prime members for a flat rate of $5 per month.
Business
Are glaucoma and obstructive sleep apnea connected?
New research assessed a 50% more likelihood for glaucoma among OSA patients from Singapore.
Business
Viatris officially acquires Oyster Point Pharma, Famy Life Sciences
The company now owns the rights to Tyrvaya as part of its newly established Viatris Eye Care Division.
Business
Harrow to acquire US rights to 5 ophthalmic products from Novartis
Acquisition marks the second deal between the two companies in less than a year.
Business
Amgen is purchasing Horizon Therapeutics
Billion-dollar deal is expected to close in early 2023.
Business
Can I have a copy of my glasses prescription? —Weekly Glance
Sure, but you may soon have to sign for it.
Business
Harrow and iOR Partners expand national product supply agreement
Harrow’s entire formulary of compounded ophthalmic products will be available to iOR Partnres' office-based surgery locations across the country.
Business
Alcon officially acquires Aerie
Alcon announced Wednesday that it has completed its purchase of Aerie Pharmaceuticals, 3 months following the companies announcing their definite merger agreement.
Business
Sightpath Medical purchases Accusite Surgical
Sightpath, a provider of mobile ophthalmic services for cataract and refractive surgery, announced it will be acquiring Accusite Surgical, a mobile cataract surgery company.
Business
Is Novartis selling its ophthalmology franchise?
A Bloomberg report claims Novartis AG is in the early stages of considering selling its ophthalmology and respiratory units in order to invest in cutting-edge medicines.
Business
Medicare reimbursement rates for glaucoma procedures on the decline
New research published in the Journal of Glaucoma shows that the average adjusted reimbursement for 22 procedures saw a near-21% decrease over the last 20 years.
Business
New exclusive license agreement gives Ocuphire rights to develop, commercialize Nyxol
The preservative-free eye drop is getting new ownership.Business
Viatris seals the deal on two ophthalmic acquisitions
Viatris just announced it will acquire Oyster Point Pharma and Famy Life Sciences.
Business